Archived press releases

2005

Benitec Featured in International Herald Tribune article December 31, 2005
Benitec Grants Sigma-Aldrich License to RNAi Patent Portfolio  October 23, 2005
Benitec Successfully Resolves Patent Infringement Litigation  October 3, 2005
Benitec Patents Upheld in Australia
Benitec and Promega Settle Litigation
August 23, 2005
Benitec Quarterly Report August 21, 2005
Benitec Granted Exclusive Worldwide License to Calando’s RNAi Delivery Technology for Benitec's Hepatitis C Therapeutic June 30, 2005
Benitec to Present Preclinical Data on its Hepatitis C Virus Program at the American Society for Gene Therapy Meeting June 20, 2005
Benitec Announces Clinical Candidate for the Treatment of Hepatitis C  May 24, 2005
Benitec Appoints Chief Financial Officer  May 9, 2005
Benitec and Alnylam Form Alliance on Fundamental Intellectual Property for April 13, 2005
RNAi Therapeutics April 12, 2005
Benitec Announces Underwritten Rights Issue to Raise Up To $9.7 Million April 6, 2005
Benitec Announces Registered Office Address Change March 30, 2005
Benitec Grants Worldwide ddRNAi License to Genoway March 22, 2005
Benitec Adds Leading Hematology Researcher and FDA Advisor to Scientific Advisory Board March 15, 2005
Appointment of Company Secretary March 1, 2005
Benitec and Combimatrix Enter Cross-Licensing and Collaboration Agreement Feb 23, 2005
Benitec Announces National Institutes of Health (NIH) Funded AIDS Collaboration Feb 21, 2005
Benitec Appoints Sara Cunningham to Board of Directors Feb. 9, 2005
Benitec and The Garvan Institute to Develop Novel Drugs for Diabetes and Obesity using Garvan's "Hotmouse" Technology Feb. 3, 2005
Benitec Appoints Alexander L. Cappello to Board of Directors Feb. 3, 2005
Benitec Online Conference Jan. 31, 2005
Appointment of Chairman and CEO Jan. 18, 2005

[back to top]

2004

Benitec Announces Litigation Status Dec. 2, 2004
Benitec Grants ddRNAi License to Artemis Pharmaceuticals GmbH, Cologne for Commercial Development of Transgenics Oct. 28, 2004
Benitec Announces Additional Non-Exclusive Worldwide License to Research Reagent Company & the Issue of Its Hong Kong Patent Oct. 20, 2004
Benitec Obtains Exclusive License to Unique RNAi Non-Viral Delivery Technology from Stanford University Oct. 15, 2004
Benitec and City of Hope Announce HIV/AIDS collaboration and Initiation of the World's First RNAi Based HIV Clinical Development Program Aug. 25, 2004
Benitec Settles Infringement Litigation with Genscript & Announces Grant of Second UK Patent Aug. 23, 2004
Benitec Announces Appointment of Capello Capital Corporation as Exclusive Strategic Advisors and Investment Bankers to the Company Aug. 16, 2004
Benitec Settles Infringement Litigation Against Ambion and Grants a Non-Exclusive Worldwide License to Make and Sell ddRNAi Products Aug. 10, 2004
Benitec and Promega Grant Non Exclusive Worldwide License to Merck to use ddRNAi in Exclusive Research Programs July 5, 2004
Benitec Expands Management Team June 18, 2004
Benitec Acquires Avocel and establishes US operations May 17, 2004
Benitec Appoints Rob Thomas (Citigroup) as Deputy Chairman May 7, 2004
Eminent Scientists Join Benitec's Scientific Advisory Board Apr 21, 2004
Appendix 4C - Highlights for Quarter ended 31 March 2004 Mar. 26, 2004
Benitec Initiates Patent Infringement Lawsuit to Protect RNAi Gene Silencing Technology Mar. 26, 2004
DNA-Delivered RNAi Products for Research Applications Launched by Promega Mar. 5, 2004
Trading of BLT Shares on the Berlin and Frankfurt Stock Exchanges Feb. 24, 2004
Promega Corporation Sub-licensed Chemicon International Feb. 18, 2004
Corporate Presentation Jan. 15, 2004

[back to top]

2003

Placement Announcement Dec. 9, 2003
Milestone Strategic Agreement Benitec CSIRO & QDPI Dec. 8, 2003
Benitec Achieves Major Breakthrough in Gene Silencing Oct. 22, 2003
Tranzyme: Tranzyme Receives Funding from North Carolina Biotechnology Center Through Small Business Research Award Program Sep. 23, 2003
Dr John Rossi to Chair Benitec's U.S. Scientific Advisory Board Sep. 18, 2003
Garvan Institute extends Diabetes Research Collaboration Jul. 17, 2003
Queensland Government: Queensland Scores Gene Technology Coup Jun. 24, 2003
Benitec Granted First US & UK Patents for DNA-Directed Gene Silencing Jun. 5, 2003
Benitec and Promega Announce Worldwide Exclusive License for RNAi Products | Promega Fact Sheet Apr. 8, 2003
Benitec and Tranzyme Announce Collaboration Agreement for Gene Silencing Technology Feb. 27, 2003
Benitec Acquires Patent for Fast-Tracking Drug Development Jan. 7, 2003

[back to top]

2002

Benitec and The Garvan Institute Collaborate on Diabetes
Benitec First to Show Stable Gene Silencing in Animals
Dec. 12, 2002
Queensland Government: Cruise Missile of Gene Technology is Biggest Biotech Breakthrough for Decade Sep. 16, 2002
Australian Biotech's Gene Silencing to Unleash a Global Storm Jun. 23, 2002

[back to top]

 
Copyright ©2007. Benitec Ltd. All rights reserved. Disclaimer : Privacy